SEC Form 4 · accession 0001209191-18-029600
HERBALIFE LTD. · HLF
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Des Walsh
Officer — Executive Vice Chairman
Period of report
May 10, 2018
Accepted (ET)
May 11, 2018 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001180262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 10, 2018 | M | 30,000 | $19.375 | A | 175,533 | D | |
| Common Stock | May 10, 2018 | D | 5,215 | $111.46 | D | 170,318 | D | |
| Common Stock | May 10, 2018 | F | 11,229 | $111.46 | D | 159,089 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation Rights | $19.375 | May 10, 2018 | M | 30,000 | D | Jun 30, 2011 | Jun 30, 2018 | Common Stock | 30,000 | 0 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2018.
- F2The reporting person received 13,556 shares of common stock upon the net exercise of 30,000 stock appreciation rights ("SARS"). The reporting person forfeited 5,215 shares of common stock underlying the SARS in payment of the exercise price and 11,229 shares of common stock underlying the SARS to satisfy the withholding tax obligation resulting from the exercise, using the closing stock price on May 10, 2018 of $111.46.